Correlation Between NetApp and Olema Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NetApp and Olema Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NetApp and Olema Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NetApp Inc and Olema Pharmaceuticals, you can compare the effects of market volatilities on NetApp and Olema Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NetApp with a short position of Olema Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NetApp and Olema Pharmaceuticals.

Diversification Opportunities for NetApp and Olema Pharmaceuticals

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between NetApp and Olema is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding NetApp Inc and Olema Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olema Pharmaceuticals and NetApp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NetApp Inc are associated (or correlated) with Olema Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olema Pharmaceuticals has no effect on the direction of NetApp i.e., NetApp and Olema Pharmaceuticals go up and down completely randomly.

Pair Corralation between NetApp and Olema Pharmaceuticals

Given the investment horizon of 90 days NetApp Inc is expected to generate 0.35 times more return on investment than Olema Pharmaceuticals. However, NetApp Inc is 2.89 times less risky than Olema Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Olema Pharmaceuticals is currently generating about -0.16 per unit of risk. If you would invest  6,764  in NetApp Inc on September 4, 2022 and sell it today you would lose (121.00)  from holding NetApp Inc or give up 1.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

NetApp Inc  vs.  Olema Pharmaceuticals

 Performance (%) 
       Timeline  
NetApp Inc 
NetApp Performance
0 of 100
Over the last 90 days NetApp Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, NetApp is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the insiders.

NetApp Price Channel

Olema Pharmaceuticals 
Olema Performance
0 of 100
Over the last 90 days Olema Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in January 2023. The current disturbance may also be a sign of long term up-swing for the company investors.

Olema Price Channel

NetApp and Olema Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NetApp and Olema Pharmaceuticals

The main advantage of trading using opposite NetApp and Olema Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NetApp position performs unexpectedly, Olema Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olema Pharmaceuticals will offset losses from the drop in Olema Pharmaceuticals' long position.
NetApp vs. Anheuser Busch Inbev
NetApp vs. Etsy Inc
NetApp vs. JPMorgan Chase Co
NetApp vs. Linde PLC
The idea behind NetApp Inc and Olema Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Olema Pharmaceuticals vs. Addex Therapeutics
Olema Pharmaceuticals vs. Apexigen
Olema Pharmaceuticals vs. Avalo Therapeutics
Olema Pharmaceuticals vs. Black Diamond Therapeutics
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go